Bronchopulmonary dysplasia: Incidence and severity in premature infants born at high altitude

Jefferson A Buendía1, Cristian Ramírez Velasquez2, Dione Benjumea-Bedoya2

  • 1Departamento de farmacología y Toxicologia, Grupo de Investigación en Farmacología y Toxicología, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.

Pediatric Pulmonology
|November 19, 2021
PubMed

Insights

Bronchopulmonary dysplasia (BPD) affects premature infants, with high-altitude birth potentially increasing incidence. Sepsis and pulmonary hypertension are key risk factors for BPD severity in these vulnerable newborns.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • High-Altitude Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a leading cause of chronic lung disease in premature infants.
  • Limited data exists on BPD epidemiology and severity at high altitudes.
  • This study focuses on preterm infants born at high altitude in Rionegro, Colombia.

Purpose of the Study:

  • To determine the frequency of BPD severity levels in preterm infants born at high altitude.
  • To identify risk factors associated with BPD severity in this population.
  • To contribute to understanding BPD in high-altitude environments.

Main Methods:

  • Retrospective analytical cohort study.
  • Included preterm infants (≤36 weeks gestational age) without major malformations.
  • Data collected from infants admitted to a neonatal intensive care unit at 2200m altitude between 2011-2018.

Main Results:

  • The incidence of BPD was 23.5% in the studied cohort.
  • BPD severity distribution: Grade 1 (69.9%), Grade 2 (15.5%), Grade 3 (14.5%).
  • Sepsis (OR 4.15) and pulmonary hypertension (OR 3.86) were significantly associated with BPD severity.

Conclusions:

  • BPD incidence at high altitude is comparable to other high-altitude cities.
  • Sepsis and pulmonary hypertension are critical factors influencing BPD severity.
  • Increased awareness and early recognition of risk factors are crucial for reducing BPD morbidity.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
426
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
379
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
466
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
591